Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Science Times Observer.

Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics
Three Phase 1 studies support once-daily inhaled administration of mosliciguat with no evidence of serious systemic side effects Results informed the ongoing Phase 2 PHocus study of mosliciguat for the treatment of pulmonary hypertension...

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025
TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia: FDA PDUFA goal date of August 15, 2025 TNX-102 SL demonstrated statistically significant improvement in the...

Scientist and Cancer Survivor Launches Podcast to Redefine Food and Health
HOUSTON, TX, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Dr. Beata Lerman, gene therapy and immuno-oncology scientist, announces the launch of Heal Me with Chocolate, a podcast dedicated to examining the impact of food on health, with a...

Qalitex Laboratories on What Supplement and Cosmetic Brands Risk Without Scientific Shelf-Life Validation
Qalitex warns supplement and cosmetic brands of the hidden risks—from failed launches to reputational damage—when products go to market unvalidated. IRVINE, CA, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- In an industry where trust plays a...

Pharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat Bradykinin-Mediated Angioedema Attacks at the EAACI Congress
ZUG, Switzerland, June 16, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated...

Able To Change Recovery: The Science and Success Behind Contingency Management Therapy
CM Therapy is a behavioral approach rooted in the science of positive reinforcement. SAN JUAN CAPISTRANO, CA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Able To Change Mental Health & Depression Treatment Center, a leading provider of...

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from...

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions
FDA assigns PDUFA target action date of January 31, 2026 WARREN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...

Stratus Therapeutics Strengthens Executive Team with Appointment of Michael P. Cooke, PhD as Chief Scientific Officer
CAMBRIDGE, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Stratus Therapeutics, Inc. (“Stratus”), a biotechnology company developing on-demand hematopoietic stem cell (HSC) therapies, today announced the appointment of Michael (Mike) P. Cooke, PhD, as...

Nokia announces changes to Group Leadership Team
Nokia Corporation Stock Exchange Release 16 June 2025 at 14:00 EEST Nokia announces changes to Group Leadership Team Federico Guillén to retire from Nokia on 31 December 2025. He will step down as President of the Network Infrastructure (NI)...

Historical Drama Meets Gritty Suspense in Call Me Charlie, the New Novel by Lisa Lynn
JOSHUA, TX, UNITED STATES, June 16, 2025 /EINPresswire.com/ -- In Call Me Charlie, author Lisa Lynn delivers a riveting blend of historical fiction, mystery, and feminist grit. Set in late 19th-century New York, the novel follows Charlotte...

DataRobot is a Leader in the 2025 Gartner® Magic Quadrant™ for Data Science and Machine Learning Platforms - Again
DataRobot, the agentic workforce platform, today announced that the company has been recognized by Gartner® as a Leader in the Magic Quadrant™ for Data Science and Machine Learning (DSML) Platforms for the second time.1 The evaluation was based on...

New panel seeks to limit pollution’s deadly toll
Pollution is widespread – and often fatal. To stem this pollution crisis, countries agreed in 2022 to establish a new body that would provide policymakers with robust, independent information on chemicals, waste and pollution prevention....

AlayaCare Announces the Launch of Layla in Canada, an AI-Powered Assistant Designed for Home Care
TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- AlayaCare, a leading provider of cloud-based home and community care solutions, is proud to announce the Canadian launch of Layla, an AI-powered conversational assistant designed to transform how care is...

New Headache Medicine Research Impacting Treatment, Prevention and Quality of Life to be Presented at the American Headache Society® 67th Annual Scientific Meeting in Minneapolis, MN
The American Headache Society® (AHS) will host its 2025 Annual Scientific Meeting on June 19-22. Attendees can participate in-person or On Demand, gaining evidence-based information on diagnosing, managing, and treating headache disorders. "We are...

H2O.ai Named a Visionary for 3rd Consecutive Year in 2025 Gartner Magic Quadrant for Data Science and Machine Learning Platforms
H2O.ai, the world’s leading Agentic AI company and a pioneer in Sovereign AI with secure, on-premise and air-gapped deployments, has been recognized as a Visionary in the 2025 Gartner® Magic Quadrant™ for Data Science and Machine Learning...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Semler Scientific Inc. - SMLR
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at...

Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass spectrometer (MS) and the Thermo Scientific™ Orbitrap™ Excedion™ Pro mass spectrometer...

Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), announces three software ecosystem enhancements at ASMS. These developments will present new ways to acquire data, new...

PCM Encore Surpasses $1.2 Billion in Client Assets, Expands Nationwide in First Six Months Serving External Families
Built over five years as a single family office, PCM Encore opened to other families six months ago and now manages over $1.2 billion. With 57 families onboard, the firm continues expanding its advisor network and direct investment capabilities...